US4029884A
(en)
|
1971-03-18 |
1977-06-14 |
Abbott Laboratories |
Adenosine-5'-carboxylic acid amides
|
CA1019727A
(en)
|
1971-03-18 |
1977-10-25 |
Abbott Laboratories |
Adenosine-5'-carboxylic acid amides
|
US3927216A
(en)
|
1971-06-01 |
1975-12-16 |
Icn Pharmaceuticals |
1,2,4-Triazol E-3-carboxamides for inhibiting virus infections
|
US3864483A
(en)
|
1972-03-22 |
1975-02-04 |
Abbott Lab |
Adenosine-5{40 -carboxylic acid amides
|
US4450150A
(en)
|
1973-05-17 |
1984-05-22 |
Arthur D. Little, Inc. |
Biodegradable, implantable drug delivery depots, and method for preparing and using the same
|
US4351337A
(en)
|
1973-05-17 |
1982-09-28 |
Arthur D. Little, Inc. |
Biodegradable, implantable drug delivery device, and process for preparing and using the same
|
US3914415A
(en)
|
1973-06-14 |
1975-10-21 |
Abbott Lab |
Adenosine-5{40 -carboxylic acid amides
|
US3914414A
(en)
|
1973-06-14 |
1975-10-21 |
Abbott Lab |
Method of increasing coronary pO{HD 2 {B in mammals
|
US3892769A
(en)
|
1973-07-20 |
1975-07-01 |
Merck & Co Inc |
Acetaminophen esters of aryl salicylic acids
|
US3980766A
(en)
|
1973-08-13 |
1976-09-14 |
West Laboratories, Inc. |
Orally administered drug composition for therapy in the treatment of narcotic drug addiction
|
DE2417465A1
(de)
|
1974-04-10 |
1975-10-30 |
Lester R Wellman |
Vorrichtung zum oeffnen und wiederverschliessen eines dicht verschlossenen flexiblen behaelters
|
US3966917A
(en)
|
1974-07-30 |
1976-06-29 |
Abbott Laboratories |
Platelet aggregation inhibitors
|
DE2530563C2
(de)
|
1975-07-09 |
1986-07-24 |
Bayer Ag, 5090 Leverkusen |
Analgetische Arzneimittel mit vermindertem Mißbrauchspotential
|
FR2313915A1
(fr)
|
1976-01-26 |
1977-01-07 |
Corneille Gilbert |
Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme
|
NO154918C
(no)
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
|
SE7804231L
(sv)
|
1978-04-14 |
1979-10-15 |
Haessle Ab |
Magsyrasekretionsmedel
|
US4308251A
(en)
|
1980-01-11 |
1981-12-29 |
Boots Pharmaceuticals, Inc. |
Controlled release formulations of orally-active medicaments
|
JPS6056122B2
(ja)
|
1980-05-21 |
1985-12-09 |
塩野義製薬株式会社 |
徐放性製剤
|
US4321253A
(en)
|
1980-08-22 |
1982-03-23 |
Beatty Morgan L |
Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
|
US4454309A
(en)
|
1980-11-12 |
1984-06-12 |
Tyndale Plains-Hunter, Ltd. |
Polyurethane polyene compositions
|
JPS57197214A
(en)
|
1981-05-29 |
1982-12-03 |
Tanabe Seiyaku Co Ltd |
Rapid-releasing microcapsule and its preparation
|
US4443549A
(en)
|
1981-10-19 |
1984-04-17 |
Molecular Genetics, Inc. |
Production of monoclonal antibodies against bacterial adhesins
|
US4434153A
(en)
|
1982-03-22 |
1984-02-28 |
Alza Corporation |
Drug delivery system comprising a reservoir containing a plurality of tiny pills
|
US4507276A
(en)
|
1982-08-20 |
1985-03-26 |
Bristol-Myers Company |
Analgesic capsule
|
US4461759A
(en)
|
1983-01-03 |
1984-07-24 |
Verex Laboratories, Inc. |
Constant release rate solid oral dosage formulations of veropamil
|
HU187215B
(en)
|
1983-01-26 |
1985-11-28 |
Egyt Gyogyszervegyeszeti Gyar |
Method for producing pharmaceutical product of high actor content and prolonged effect
|
US4833905A
(en)
|
1983-06-03 |
1989-05-30 |
Micromatic Textron Inc. |
Method for splining clutch hubs with close tolerance spline bellmouth and oil seal surface roundness
|
JPS6051189A
(ja)
|
1983-08-30 |
1985-03-22 |
Sankyo Co Ltd |
チアゾリジン誘導体およびその製造法
|
JPS60100516A
(ja)
|
1983-11-04 |
1985-06-04 |
Takeda Chem Ind Ltd |
徐放型マイクロカプセルの製造法
|
US4894240A
(en)
|
1983-12-22 |
1990-01-16 |
Elan Corporation Plc |
Controlled absorption diltiazem formulation for once-daily administration
|
IL75400A
(en)
|
1984-06-16 |
1988-10-31 |
Byk Gulden Lomberg Chem Fab |
Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
|
JPS6150978A
(ja)
|
1984-08-16 |
1986-03-13 |
Takeda Chem Ind Ltd |
ピリジン誘導体およびその製造法
|
AU4640985A
(en)
|
1984-08-31 |
1986-03-06 |
Nippon Chemiphar Co. Ltd. |
Benzimidazole derivatives
|
ATE60340T1
(de)
|
1984-10-19 |
1991-02-15 |
Battelle Memorial Institute |
Durch mikroorganismen abbaubares polypeptid und seine verwendung fuer die fortschreitende abgabe von medikamenten.
|
EP0198769A3
(de)
|
1985-04-12 |
1987-09-02 |
Forest Laboratories, Inc. |
Schwimmfähige therapeutische Mittel mit verzögerter Freisetzung
|
EP0202027A1
(de)
|
1985-04-18 |
1986-11-20 |
Sumitomo Chemical Company, Limited |
Herbizide Zusammensetzung
|
US4728512A
(en)
|
1985-05-06 |
1988-03-01 |
American Home Products Corporation |
Formulations providing three distinct releases
|
LU85943A1
(fr)
|
1985-06-12 |
1987-01-13 |
Galephar |
Comprimes pharmaceutiques permettant l'administration aisee de pellets, leur preparation et leur utilisation
|
IT1185177B
(it)
*
|
1985-07-03 |
1987-11-04 |
Metalvuoto Films Spa |
Dispositivo per realizzare film plastici metallizzati presentanti zone ben delimitate prive di metallizzazione
|
US5002551A
(en)
|
1985-08-22 |
1991-03-26 |
Johnson & Johnson Medical, Inc. |
Method and material for prevention of surgical adhesions
|
US4693896A
(en)
|
1985-10-07 |
1987-09-15 |
Fmc Corporation |
Ethylcellulose-coated, gastric-disintegrable aspirin tablet
|
DE3543999A1
(de)
|
1985-12-13 |
1987-06-19 |
Bayer Ag |
Hochreine acarbose
|
CA1327010C
(en)
|
1986-02-13 |
1994-02-15 |
Tadashi Makino |
Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
|
AU591248B2
(en)
|
1986-03-27 |
1989-11-30 |
Kinaform Technology, Inc. |
Sustained-release pharaceutical preparation
|
SE8601624D0
(sv)
|
1986-04-11 |
1986-04-11 |
Haessle Ab |
New pharmaceutical preparations
|
WO1987007833A1
(en)
|
1986-06-20 |
1987-12-30 |
Shacknai Jonah |
Oral sustained release medicament
|
US4925673A
(en)
|
1986-08-18 |
1990-05-15 |
Clinical Technologies Associates, Inc. |
Delivery systems for pharmacological agents encapsulated with proteinoids
|
IT1200217B
(it)
|
1986-09-30 |
1989-01-05 |
Valducci Roberto |
Membrana per uso farmaceutico ed industriale
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
SE8605515D0
(sv)
|
1986-12-22 |
1986-12-22 |
Astra Laekemedel Ab |
A liquid dosage form for oral administration of a pharmaceutically active substance
|
US5026560A
(en)
|
1987-01-29 |
1991-06-25 |
Takeda Chemical Industries, Ltd. |
Spherical granules having core and their production
|
ES2061623T3
(es)
|
1987-03-02 |
1994-12-16 |
Brocades Pharma Bv |
Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.
|
GB8705083D0
(en)
|
1987-03-04 |
1987-04-08 |
Euro Celtique Sa |
Spheroids
|
US4902513A
(en)
*
|
1987-07-31 |
1990-02-20 |
Jean Carvais |
Oral sustained release medicament
|
US4837031A
(en)
|
1987-09-17 |
1989-06-06 |
Mallinckrodt, Inc. |
Compositions containing ibuprofen
|
US4961932A
(en)
|
1987-10-26 |
1990-10-09 |
Alza Corporation |
Plurality of tiny pills in liquid dosage form
|
DE3810757A1
(de)
|
1988-03-30 |
1989-10-26 |
Freudenberg Carl Fa |
Verfahren zur herstellung einer mikroporoesen folie
|
US5268182A
(en)
|
1988-06-24 |
1993-12-07 |
Abbott Laboratories |
Sustained-release drug dosage units of terazosin
|
FR2634377B1
(fr)
|
1988-06-30 |
1991-09-27 |
Cortial |
Nouvelle forme pharmaceutique a liberation prolongee a base d'un complexe resine-principe actif
|
US5028434A
(en)
|
1988-07-21 |
1991-07-02 |
Alza Corporation |
Method for administering nilvadipine for treating cardiovascular symptoms
|
IT1226940B
(it)
*
|
1988-09-16 |
1991-02-22 |
Recordati Chem Pharm |
Sistema terapeutico a rilascio controllato per formulazioni farmaceutiche liquide
|
FI894611A
(fi)
|
1988-09-30 |
1990-03-31 |
May & Baker Ltd |
Granulaera farmaceutiska preparat.
|
US4999189A
(en)
*
|
1988-11-14 |
1991-03-12 |
Schering Corporation |
Sustained release oral suspensions
|
US5186930A
(en)
*
|
1988-11-14 |
1993-02-16 |
Schering Corporation |
Sustained release oral suspensions
|
IT1227899B
(it)
*
|
1988-12-23 |
1991-05-14 |
Poli Ind Chimica Spa |
Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
|
CA2007181C
(en)
|
1989-01-06 |
1998-11-24 |
Angelo Mario Morella |
Sustained release pharmaceutical composition
|
FR2642080B1
(fr)
|
1989-01-23 |
1992-10-02 |
Onera (Off Nat Aerospatiale) |
Polysilanes et leur procede de preparation
|
US4948581A
(en)
|
1989-02-17 |
1990-08-14 |
Dojin Iyaku-Kako Co., Ltd. |
Long acting diclofenac sodium preparation
|
US5026559A
(en)
|
1989-04-03 |
1991-06-25 |
Kinaform Technology, Inc. |
Sustained-release pharmaceutical preparation
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
US5084278A
(en)
|
1989-06-02 |
1992-01-28 |
Nortec Development Associates, Inc. |
Taste-masked pharmaceutical compositions
|
AU632602B2
(en)
|
1989-08-02 |
1993-01-07 |
John David Arnold |
Method and preparation for reducing risk of myocardial infarction
|
NZ233975A
(en)
|
1989-08-16 |
1992-06-25 |
Sterling Drug Inc |
Aspirin granules coated with a gastroprotectant
|
IT1256651B
(it)
|
1992-12-11 |
1995-12-12 |
Giancarlo Santus |
Composizione farmaceutica a rilascio controllato in sospensione liquida
|
JP2571874B2
(ja)
|
1989-11-06 |
1997-01-16 |
アルカーメス コントロールド セラピューティクス,インコーポレイテッド |
タンパク質マイクロスフェア組成物
|
AU634606B2
(en)
|
1989-11-06 |
1993-02-25 |
Alkermes Controlled Therapeutics, Inc. |
Method for producing protein microspheres
|
US5248516A
(en)
|
1989-12-19 |
1993-09-28 |
Fmc Corporation |
Film-forming composition: method of producing same and use for coating pharmaceuticals and foods and the like
|
GB9002495D0
(en)
|
1990-02-05 |
1990-04-04 |
Monsanto Europe Sa |
Glyphosate compositions
|
US5206030A
(en)
|
1990-02-26 |
1993-04-27 |
Fmc Corporation |
Film-forming composition and use for coating pharmaceuticals, foods and the like
|
IT1246383B
(it)
|
1990-04-17 |
1994-11-18 |
Eurand Int |
Metodo per il mascheramento del sapore di farmaci
|
WO1991019486A1
(en)
|
1990-06-14 |
1991-12-26 |
Kalmo Enterprises, Inc. |
Stable aqueous drug suspensions
|
CA2083606C
(en)
|
1990-06-20 |
2001-08-21 |
Arne Elof Brandstrom |
Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
|
SE9002206D0
(sv)
|
1990-06-20 |
1990-06-20 |
Haessle Ab |
New compounds
|
WO1992001446A1
(en)
|
1990-07-20 |
1992-02-06 |
Aps Research Limited |
Sustained-release formulations
|
SE9002684D0
(sv)
|
1990-08-17 |
1990-08-17 |
Malvac Foundation C O Peter Pe |
New peptides and their use
|
EP0477135A1
(de)
|
1990-09-07 |
1992-03-25 |
Warner-Lambert Company |
Kaubare kugelige überzogene Mikrokapseln und Verfahren zu ihrer Herstellung
|
GB9022788D0
(en)
|
1990-10-19 |
1990-12-05 |
Cortecs Ltd |
Pharmaceutical formulations
|
US5219895A
(en)
|
1991-01-29 |
1993-06-15 |
Autogenesis Technologies, Inc. |
Collagen-based adhesives and sealants and methods of preparation and use thereof
|
US5431922A
(en)
|
1991-03-05 |
1995-07-11 |
Bristol-Myers Squibb Company |
Method for administration of buspirone
|
GB9104854D0
(en)
|
1991-03-07 |
1991-04-17 |
Reckitt & Colmann Prod Ltd |
Sustained release compositions
|
FI922107A0
(fi)
|
1991-05-10 |
1992-05-08 |
Faulding F H & Co Ltd |
Mikrokapselkomposition och foerfarande.
|
US5286497A
(en)
|
1991-05-20 |
1994-02-15 |
Carderm Capital L.P. |
Diltiazem formulation
|
IT1250421B
(it)
|
1991-05-30 |
1995-04-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
|
US5464632C1
(en)
|
1991-07-22 |
2001-02-20 |
Prographarm Lab |
Rapidly disintegratable multiparticular tablet
|
FR2679451B1
(fr)
|
1991-07-22 |
1994-09-09 |
Prographarm Laboratoires |
Comprime multiparticulaire a delitement rapide.
|
DE69220317T2
(de)
|
1991-10-01 |
1997-10-16 |
Takeda Chemical Industries Ltd |
Mikropartikeln-Zusammenfassung zur verlängerten Freigabe und Herstellung derselbe
|
US5656295A
(en)
|
1991-11-27 |
1997-08-12 |
Euro-Celtique, S.A. |
Controlled release oxycodone compositions
|
US5409709A
(en)
|
1991-11-29 |
1995-04-25 |
Lion Corporation |
Antipyretic analgesic preparation containing ibuprofen
|
DE4200821A1
(de)
*
|
1992-01-15 |
1993-07-22 |
Bayer Ag |
Geschmacksmaskierte pharmazeutische mittel
|
US5571533A
(en)
|
1992-02-07 |
1996-11-05 |
Recordati, S.A., Chemical And Pharmaceutical Company |
Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
|
US5272137A
(en)
*
|
1992-02-14 |
1993-12-21 |
Mcneil-Pfc, Inc. |
Aqueous pharmaceutical suspension for pharmaceutical actives
|
US5286495A
(en)
|
1992-05-11 |
1994-02-15 |
University Of Florida |
Process for microencapsulating cells
|
KR940003548U
(ko)
|
1992-08-14 |
1994-02-21 |
김형술 |
세탁물 건조기
|
IL103224A
(en)
|
1992-09-18 |
1998-08-16 |
Teva Pharma |
Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
|
WO1994009762A1
(en)
|
1992-11-05 |
1994-05-11 |
Merck & Co., Inc. |
Drug delivery device
|
US5594016A
(en)
|
1992-12-28 |
1997-01-14 |
Mitsubishi Chemical Corporation |
Naphthalene derivatives
|
FR2704146B1
(fr)
|
1993-04-19 |
1995-07-13 |
Cripdom |
Microcapsules d'acide acétylsalicylique à libération contrôlée.
|
SE9301830D0
(sv)
|
1993-05-28 |
1993-05-28 |
Ab Astra |
New compounds
|
FR2708932B1
(fr)
|
1993-08-10 |
1995-11-10 |
Flamel Tech Sa |
Procédé de préparation de polyaminoacides.
|
HU218673B
(hu)
|
1993-10-07 |
2000-10-28 |
Euroceltique S.A. |
Opioid analgetikumot tartalmazó elnyújtott hatóanyag-felszabadítású orális gyógyszerkészítmény és eljárás előállítására
|
GB9401894D0
(en)
|
1994-02-01 |
1994-03-30 |
Rhone Poulenc Rorer Ltd |
New compositions of matter
|
IT1269578B
(it)
*
|
1994-04-22 |
1997-04-08 |
Chiesi Farma Spa |
Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base.
|
MX9605419A
(es)
|
1994-05-06 |
1997-12-31 |
Pfizer |
Formas de dosificacion de liberacion controlada de azitromicina.
|
IT1270594B
(it)
*
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
JPH0873345A
(ja)
|
1994-09-05 |
1996-03-19 |
Terumo Corp |
医薬製剤
|
DE4432757A1
(de)
|
1994-09-14 |
1996-03-21 |
Boehringer Mannheim Gmbh |
Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
|
FR2724563A1
(fr)
|
1994-09-15 |
1996-03-22 |
Coletica |
Utilisation de membranes collageniques comme protheses de regeneration peritoneale
|
FR2725623A1
(fr)
|
1994-10-18 |
1996-04-19 |
Flamel Tech Sa |
Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
|
US5858398A
(en)
|
1994-11-03 |
1999-01-12 |
Isomed Inc. |
Microparticular pharmaceutical compositions
|
GB9423588D0
(en)
|
1994-11-22 |
1995-01-11 |
Glaxo Wellcome Inc |
Compositions
|
KR0167613B1
(ko)
|
1994-12-28 |
1999-01-15 |
한스 루돌프 하우스, 니콜 케르커 |
사이클로스포린-함유 연질캅셀제 조성물
|
US5834024A
(en)
|
1995-01-05 |
1998-11-10 |
Fh Faulding & Co. Limited |
Controlled absorption diltiazem pharmaceutical formulation
|
JP2690276B2
(ja)
|
1995-01-10 |
1997-12-10 |
科学技術振興事業団 |
静電結合型高分子ミセル薬物担体とその薬剤
|
FR2732218B1
(fr)
|
1995-03-28 |
1997-08-01 |
Flamel Tech Sa |
Particules a base de polyaminoacide(s) et susceptibles d'etre utilisees comme vecteurs de principe(s) actif(s) et leurs procedes de preparation
|
US5750468A
(en)
|
1995-04-10 |
1998-05-12 |
Monsanto Company |
Glyphosate formulations containing etheramine surfactants
|
US5674529A
(en)
|
1995-06-06 |
1997-10-07 |
Church & Dwight Co., Inc. |
Alkalinizing potassium salt controlled release preparations
|
US5945124A
(en)
|
1995-07-05 |
1999-08-31 |
Byk Gulden Chemische Fabrik Gmbh |
Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
|
GB9514285D0
(en)
|
1995-07-13 |
1995-09-13 |
Univ Nottingham |
Polymeric lamellar substrate particles for drug delivery
|
NZ318282A
(en)
|
1995-09-07 |
2000-01-28 |
Smithkline Beecham Corp |
Pharmaceutical formulation containing amoxycillin and clavulanate in a weight ratio of 12:1 and 20:1
|
DE69636413T2
(de)
|
1995-11-13 |
2007-03-29 |
North West University |
Verabreichungsmedium für analgetische, entzündungshemmende und antipyretische wirkstoffe und pharmazeutische zusammensetzungen enthaltend solches medium und wirkstoffe
|
IT1276130B1
(it)
|
1995-11-14 |
1997-10-27 |
Gentili Ist Spa |
Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
|
CA2238975A1
(en)
|
1995-12-12 |
1997-06-19 |
Merck & Co., Inc. |
New use for losartan
|
SE9600071D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral formulation of two active ingredients I
|
US6245351B1
(en)
|
1996-03-07 |
2001-06-12 |
Takeda Chemical Industries, Ltd. |
Controlled-release composition
|
FR2746035B1
(fr)
|
1996-03-15 |
1998-06-12 |
|
Microparticules de gel composite susceptibles d'etre utilisees comme vecteur(s) de principe(s) actif(s), l'un de leurs procedes de preparation et leurs applications
|
US20030064108A1
(en)
|
1996-04-23 |
2003-04-03 |
Stefan Lukas |
Taste masked pharmaceutical compositions
|
DE19628341C2
(de)
*
|
1996-07-13 |
1998-09-17 |
Sihl Gmbh |
Aufzeichnungsmaterial für Tintenstrahlverfahren mit wäßriger Tinte und Verwendung zum Herstellen wasserfester und lichtbeständiger Aufzeichnungen auf diesem Material
|
FR2752732B1
(fr)
*
|
1996-08-28 |
1998-11-20 |
Pf Medicament |
Forme galenique a liberation prolongee de milnacipran
|
US5780055A
(en)
|
1996-09-06 |
1998-07-14 |
University Of Maryland, Baltimore |
Cushioning beads and tablet comprising the same capable of forming a suspension
|
AU5101798A
(en)
|
1996-12-04 |
1998-06-29 |
Bristol-Myers Squibb Company |
Method for oral administration of buspirone
|
WO1998026803A1
(fr)
|
1996-12-19 |
1998-06-25 |
Daiichi Pharmaceutical Co., Ltd. |
Composition pharmaceutique pour administration par voie orale
|
FR2759083B1
(fr)
|
1997-02-06 |
1999-04-30 |
Dev Des Utilisations Du Collag |
Materiau collagenique utile notamment pour la prevention d'adherences post-operatoires
|
US5981761A
(en)
|
1997-03-27 |
1999-11-09 |
Solutia Inc. |
Crosslinked polyaspartate salts a process for their production
|
US6162463A
(en)
|
1997-05-01 |
2000-12-19 |
Dov Pharmaceutical Inc |
Extended release formulation of diltiazem hydrochloride
|
WO1998053680A1
(en)
|
1997-05-30 |
1998-12-03 |
Monsanto Company |
Process and compositions promoting biological effectiveness of exogenous chemical substances in plants
|
ES2248908T7
(es)
|
1997-06-06 |
2014-11-24 |
Depomed, Inc. |
Formas de dosificación de fármacos por vía oral y retención gástrica para liberación continuada de fármacos altamente solubles
|
JP3677156B2
(ja)
|
1997-09-05 |
2005-07-27 |
武田薬品工業株式会社 |
医薬
|
WO1999013864A2
(en)
|
1997-09-19 |
1999-03-25 |
Shire Laboratories, Inc. |
Solid solution beadlet
|
US6472373B1
(en)
|
1997-09-21 |
2002-10-29 |
Schering Corporation |
Combination therapy for eradicating detectable HCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection
|
FR2771291B1
(fr)
|
1997-11-21 |
2000-02-25 |
Ethypharm Lab Prod Ethiques |
Spheroides, procede de preparation et compositions pharmaceutiques
|
US6444246B1
(en)
|
1997-12-16 |
2002-09-03 |
Mccormick & Company, Inc. |
Cake-resistant, hygroscopically sensitive materials and process for producing the same
|
BR9813826A
(pt)
|
1997-12-22 |
2000-10-10 |
Euro Celtique Sa |
Potencial de uso abusivo de administração oral de opióide analgésico
|
SE9704869D0
(sv)
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulaton II
|
NZ506202A
(en)
|
1998-03-19 |
2003-10-31 |
Bristol Myers Squibb Co |
Biphasic controlled release delivery system for high solubility pharmaceuticals and method
|
YU51300A
(sh)
|
1998-03-20 |
2002-09-19 |
Cowa Co. Ltd. |
Adhezivna farmaceutska kompozicija za želudac i/ili dvanaestopalačno crevo
|
US6099859A
(en)
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
US6184220B1
(en)
*
|
1998-03-27 |
2001-02-06 |
Boehringer Ingelheim Pharma Kg |
Oral suspension of pharmaceutical substance
|
IL138765A0
(en)
|
1998-03-30 |
2001-10-31 |
Rtp Pharma Inc |
Compositions containing microparticles of water-insoluble substances and method for their preparation
|
US5945123A
(en)
|
1998-04-02 |
1999-08-31 |
K-V Pharmaceutical Company |
Maximizing effectiveness of substances used to improve health and well being
|
DK0974356T3
(da)
|
1998-07-15 |
2003-10-27 |
Merck Sante Sas |
Tabletter omfattende en kombination af metformin og glibenclamid
|
CA2338780C
(en)
|
1998-07-28 |
2007-01-02 |
Tanabe Seiyaku Co., Ltd. |
Preparation capable of releasing medicinal substance at targeted site in intestine
|
US20020068365A1
(en)
|
1998-07-28 |
2002-06-06 |
Eric H. Kuhrts |
Controlled release nitric oxide producing agents
|
US6179862B1
(en)
|
1998-08-14 |
2001-01-30 |
Incept Llc |
Methods and apparatus for in situ formation of hydrogels
|
US6099862A
(en)
|
1998-08-31 |
2000-08-08 |
Andrx Corporation |
Oral dosage form for the controlled release of a biguanide and sulfonylurea
|
US6303607B1
(en)
|
1998-09-10 |
2001-10-16 |
Cv Therapeutics, Inc. |
Method for administering a sustained release ranolanolazine formulation
|
AU6283299A
(en)
|
1998-10-01 |
2000-04-17 |
Elan Pharma International Limited |
Controlled release nanoparticulate compositions
|
JP2000128774A
(ja)
|
1998-10-26 |
2000-05-09 |
Tanabe Seiyaku Co Ltd |
薬物を含有する球形微粒子の製法
|
WO2000025752A1
(en)
|
1998-11-02 |
2000-05-11 |
Church, Marla, J. |
Multiparticulate modified release composition
|
NZ511614A
(en)
|
1998-11-12 |
2003-12-19 |
Smithkline Beecham P |
Modified release pharmaceutical composition containing the insulin sensitiser 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and the antidiabetic agent metaformin
|
FR2786098B1
(fr)
|
1998-11-20 |
2003-05-30 |
Flamel Tech Sa |
Particules a base de polyaminoacide(s) et susceptibles d'etre utilisees comme vecteurs de principe(s) actif(s), suspension colloidale les comprenant et leurs procedes de fabrication
|
US6419960B1
(en)
|
1998-12-17 |
2002-07-16 |
Euro-Celtique S.A. |
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
|
DE19860698A1
(de)
|
1998-12-30 |
2000-07-06 |
Hexal Ag |
Neue pharmazeutische Zusammensetzung
|
JP3645816B2
(ja)
|
1999-02-23 |
2005-05-11 |
ユハン・コーポレーション |
ロラタジン及びプソイドエフェドリンを含有する医薬カプセル組成物
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US7374779B2
(en)
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
US6566560B2
(en)
|
1999-03-22 |
2003-05-20 |
Immugen Pharmaceuticals, Inc. |
Resorcinolic compounds
|
AU767177B2
(en)
|
1999-04-13 |
2003-11-06 |
Beecham Pharmaceuticals (Pte) Limited |
Novel method of treatment
|
US7576131B2
(en)
|
1999-06-04 |
2009-08-18 |
Metabolex, Inc. |
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
|
SE9902386D0
(sv)
|
1999-06-22 |
1999-06-22 |
Astra Ab |
New formulation
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
WO2001008661A2
(en)
|
1999-07-29 |
2001-02-08 |
Roxane Laboratories, Inc. |
Opioid sustained-released formulation
|
US20030118641A1
(en)
|
2000-07-27 |
2003-06-26 |
Roxane Laboratories, Inc. |
Abuse-resistant sustained-release opioid formulation
|
DE19940740A1
(de)
*
|
1999-08-31 |
2001-03-01 |
Gruenenthal Gmbh |
Pharmazeutische Salze
|
NZ517559A
(en)
*
|
1999-08-31 |
2004-08-27 |
Gruenenthal Chemie |
Sustained release pharmaceutical composition containing tramadol saccharinate
|
ES2168043B1
(es)
|
1999-09-13 |
2003-04-01 |
Esteve Labor Dr |
Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
|
US6264983B1
(en)
|
1999-09-16 |
2001-07-24 |
Rhodia, Inc. |
Directly compressible, ultra fine acetaminophen compositions and process for producing same
|
CO5200844A1
(es)
|
1999-09-17 |
2002-09-27 |
Novartis Ag |
Una combinacion que comprende nateglinida y cuando por menos otro compuesto antidiabetico usada para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con dibetes
|
US6586438B2
(en)
|
1999-11-03 |
2003-07-01 |
Bristol-Myers Squibb Co. |
Antidiabetic formulation and method
|
HU229352B1
(en)
|
1999-11-03 |
2013-11-28 |
Bristol Myers Squibb Co |
Medicament comprising the combination of metformin and glyburide
|
FR2801226B1
(fr)
|
1999-11-23 |
2002-01-25 |
Flamel Tech Sa |
Suspension colloidale de particules submicroniques de vectorisation de principes actifs et son mode de preparation
|
DE19961897A1
(de)
*
|
1999-12-20 |
2001-06-28 |
Basf Ag |
Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
|
US6248359B1
(en)
|
2000-01-05 |
2001-06-19 |
Laboratorios Phoenix U.S.A., Inc. |
Multi-tablet oxybutynin system for treating incontinence
|
US7785625B2
(en)
|
2000-01-14 |
2010-08-31 |
Lg Life Sciences, Limited |
Lipophilic-coated microparticle containing a protein drug and formulation comprising same
|
SI1299104T1
(sl)
|
2000-02-08 |
2009-10-31 |
Euro Celtique Sa |
Oralne formulacije opioidnih agonistov, varne pred zlorabo
|
AU2001232020A1
(en)
|
2000-02-09 |
2001-08-20 |
West Pharmaceutical Services Drug Delivery And Clinical Research Centre Limited |
Floating drug delivery composition
|
US6627223B2
(en)
*
|
2000-02-11 |
2003-09-30 |
Eurand Pharmaceuticals Ltd. |
Timed pulsatile drug delivery systems
|
US6534651B2
(en)
|
2000-04-06 |
2003-03-18 |
Inotek Pharmaceuticals Corp. |
7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof
|
US6951534B2
(en)
|
2000-06-13 |
2005-10-04 |
Acorn Cardiovascular, Inc. |
Cardiac support device
|
US6815542B2
(en)
|
2000-06-16 |
2004-11-09 |
Ribapharm, Inc. |
Nucleoside compounds and uses thereof
|
JP2002003366A
(ja)
|
2000-06-23 |
2002-01-09 |
Freunt Ind Co Ltd |
固形薬剤用水系コーティング剤組成物
|
KR100496749B1
(ko)
|
2000-07-05 |
2005-06-22 |
아사히 가세이 가부시키가이샤 |
셀룰로스 분말
|
FR2811571B1
(fr)
|
2000-07-11 |
2002-10-11 |
Flamel Tech Sa |
Composition pharmaceutique orale, permettant la liberation controlee et l'absorption prolongee d'un principe actif
|
IT1318625B1
(it)
|
2000-07-14 |
2003-08-27 |
Roberto Valducci |
Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente.
|
US6541014B2
(en)
|
2000-10-13 |
2003-04-01 |
Advancis Pharmaceutical Corp. |
Antiviral product, use and formulation thereof
|
US7074417B2
(en)
|
2000-10-13 |
2006-07-11 |
Advancis Pharmaceutical Corporation |
Multiple-delayed release anti-viral product, use and formulation thereof
|
US6499158B1
(en)
|
2000-10-30 |
2002-12-31 |
Steris, Inc. |
Surgical table top and accessory clamp used thereon
|
FR2816840B1
(fr)
|
2000-11-17 |
2004-04-09 |
Flamel Tech Sa |
Medicament a base de microcapsules d'anti-hyperclycemiant a liberation prolongee et son procede de preparation
|
ATE425731T1
(de)
|
2000-12-28 |
2009-04-15 |
Tap Pharmaceutical Prod Inc |
Pharmazeutische zusammensetzungen eines nichtmagensaftresistenten protonenpumpen-hemmers mit einer carbonat- und bicarbonatsalzkombination
|
AU2002257582A1
(en)
|
2001-02-14 |
2002-09-04 |
Glaxo Wellcome S.A. |
Pharmaceutical formulation
|
CA2440069A1
(en)
*
|
2001-03-05 |
2002-09-12 |
Ortho-Mcneil Pharmaceutical, Inc. |
Taste masked pharmaceutical compositions
|
FR2821745B1
(fr)
|
2001-03-09 |
2004-07-02 |
Ethypharm Lab Prod Ethiques |
Granules et granules enrobes au gout masque
|
BR0102252B1
(pt)
|
2001-04-10 |
2013-10-22 |
|
Sistema de liberação controlada para antagonista do receptor AT1 da angiotensina II, composição farmacêutica e seu uso
|
WO2002085335A1
(en)
|
2001-04-18 |
2002-10-31 |
Nostrum Pharmaceuticals Inc. |
A novel coating for a sustained release pharmaceutical composition
|
FR2825023B1
(fr)
|
2001-05-23 |
2005-04-15 |
Flamel Tech Sa |
Forme pharmaceutique orale antidiabetique "une prise par jour"comprenant une biguanide et au moins un autre principe actif
|
GB0114532D0
(en)
|
2001-06-14 |
2001-08-08 |
Jagotec Ag |
Novel compositions
|
US7332182B2
(en)
|
2001-08-06 |
2008-02-19 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
|
US7842307B2
(en)
|
2001-08-06 |
2010-11-30 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
|
KR20040060917A
(ko)
|
2001-08-06 |
2004-07-06 |
유로-셀티크 소시에떼 아노뉨 |
오피오이드 남용을 방지하기 위한 조성물 및 방법
|
IL160217A0
(en)
|
2001-08-06 |
2004-07-25 |
Euro Celtique Sa |
Compositions and methods to prevent abuse of opioids
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
EP1418886A1
(de)
|
2001-08-10 |
2004-05-19 |
Beiersdorf AG |
Kosmetische reinigungsrezepturen auf basis einer kombination von natriumlaurethsulfat und alkylpolyamphopolycarboxyglycinaten
|
US20030083286A1
(en)
|
2001-08-22 |
2003-05-01 |
Ching-Leou Teng |
Bioadhesive compositions and methods for enhanced intestinal drug absorption
|
US6669955B2
(en)
|
2001-08-28 |
2003-12-30 |
Longwood Pharmaceutical Research, Inc. |
Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
|
US20030099711A1
(en)
*
|
2001-08-29 |
2003-05-29 |
David Meadows |
Sustained release preparations
|
US20030050620A1
(en)
|
2001-09-07 |
2003-03-13 |
Isa Odidi |
Combinatorial type controlled release drug delivery device
|
US20030059397A1
(en)
|
2001-09-17 |
2003-03-27 |
Lyn Hughes |
Dosage forms
|
US20030068276A1
(en)
|
2001-09-17 |
2003-04-10 |
Lyn Hughes |
Dosage forms
|
FR2830447B1
(fr)
|
2001-10-09 |
2004-04-16 |
Flamel Tech Sa |
Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
GB0124459D0
(en)
|
2001-10-11 |
2001-12-05 |
Novartis Ag |
Organic compounds
|
JP2005508358A
(ja)
|
2001-10-25 |
2005-03-31 |
デポメド・インコーポレイテッド |
胃滞留型ロサルタン投与量を用いる治療方法
|
US20030091630A1
(en)
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
US20030104052A1
(en)
|
2001-10-25 |
2003-06-05 |
Bret Berner |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
US20040126428A1
(en)
|
2001-11-02 |
2004-07-01 |
Lyn Hughes |
Pharmaceutical formulation including a resinate and an aversive agent
|
US7101572B2
(en)
*
|
2001-12-07 |
2006-09-05 |
Unilab Pharmatech, Ltd. |
Taste masked aqueous liquid pharmaceutical composition
|
FR2837100B1
(fr)
|
2002-03-18 |
2004-07-23 |
Flamel Tech Sa |
Comprimes a bases de microcapsules a liberation modifiee
|
WO2003080069A1
(en)
|
2002-03-18 |
2003-10-02 |
Pharmacia Corporation |
Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
|
US20050089572A1
(en)
|
2002-03-22 |
2005-04-28 |
Manoj Kumar |
Controlled release drug delivery system of pravastatin
|
US7790215B2
(en)
|
2002-03-26 |
2010-09-07 |
Purdue Pharma Lp |
Sustained-release gel coated compositions
|
WO2003084517A2
(fr)
|
2002-04-09 |
2003-10-16 |
Flamel Technologies |
Suspension orale de microcapsules d’amoxicilline
|
PT1492511E
(pt)
|
2002-04-09 |
2009-04-09 |
Flamel Tech Sa |
Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s)
|
US20050106249A1
(en)
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
WO2003094899A1
(es)
|
2002-05-09 |
2003-11-20 |
Diffucap-Chemobras Química E Farmacéutica, Ltda. |
Nuevo procedimiento para la preparacion de composiciones de liberacion programada conteniendo (s) -1- [n-[1-(ethoxycarbonyl)-3-phenylpropyl]-l-alanyl]-l-proline, y al producto obtenido por dicho procedimiento
|
AU2003229005A1
(en)
|
2002-05-10 |
2003-11-11 |
Merck And Co., Inc. |
Combination therapy for treating cyclooxygenase-2 mediated diseases in patients at risk of thrombotic cardiovascular events
|
AU2003245345A1
(en)
|
2002-05-31 |
2003-12-19 |
Alza Corporation |
Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
|
FR2840614B1
(fr)
|
2002-06-07 |
2004-08-27 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
|
US7771707B2
(en)
|
2004-06-12 |
2010-08-10 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent drug formulations
|
WO2004004693A1
(en)
|
2002-07-05 |
2004-01-15 |
Collgegium Pharmaceutical |
Abuse-deterrent pharmaceutical compositions of opiods and other drugs
|
NZ520149A
(en)
|
2002-07-12 |
2003-01-31 |
Reinforced Concrete Pipes Pty |
Anchoring device
|
US20040208936A1
(en)
|
2002-07-22 |
2004-10-21 |
Roland Chorin |
Novel compositions
|
FR2842735B1
(fr)
|
2002-07-26 |
2006-01-06 |
Flamel Tech Sa |
Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
|
FR2842736B1
(fr)
|
2002-07-26 |
2005-07-22 |
Flamel Tech Sa |
Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
|
FR2843117B1
(fr)
|
2002-07-30 |
2004-10-15 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
|
US6727839B2
(en)
|
2002-08-23 |
2004-04-27 |
Broadcom Corporation |
High speed, low power comparator
|
US7538094B2
(en)
|
2002-09-19 |
2009-05-26 |
Three Rivers Pharmacueticals, Llc |
Composition containing ribavirin and use thereof
|
JP5189242B2
(ja)
|
2002-09-23 |
2013-04-24 |
アルケルメス ファーマ アイルランド リミテッド |
乱用抵抗性の医薬組成物
|
SE0203065D0
(sv)
|
2002-10-16 |
2002-10-16 |
Diabact Ab |
Gastric acid secretion inhibiting composition
|
MY148805A
(en)
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
DE10250084A1
(de)
|
2002-10-25 |
2004-05-06 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
TWI332507B
(en)
|
2002-11-19 |
2010-11-01 |
Hoffmann La Roche |
Antiviral nucleoside derivatives
|
US20040110781A1
(en)
|
2002-12-05 |
2004-06-10 |
Harmon Troy M. |
Pharmaceutical compositions containing indistinguishable drug components
|
JP2004188307A
(ja)
|
2002-12-11 |
2004-07-08 |
Japan Atom Energy Res Inst |
リン酸基を有するジルコニウム担持繊維状吸着材の合成方法、及びそれを用いたヒ素の除去
|
BR0317275A
(pt)
|
2002-12-11 |
2005-11-08 |
Pfizer Prod Inc |
Liberação controlada de uma substância ativa em um ambiente de gordura alta
|
JP4865330B2
(ja)
|
2002-12-13 |
2012-02-01 |
デュレクト コーポレーション |
経口ドラッグデリバリーシステム
|
AU2003301121A1
(en)
|
2002-12-18 |
2004-07-14 |
Pain Therapeutics, Inc. |
Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
|
US20060210620A1
(en)
|
2003-01-21 |
2006-09-21 |
Kumra Pannanchukunnath M |
Co-precipitated amorphous losartan and dosage forms comprising the same
|
WO2004087175A1
(en)
|
2003-04-04 |
2004-10-14 |
Pharmacia Corporation |
Oral extended release compressed tablets of multiparticulates
|
MY135852A
(en)
|
2003-04-21 |
2008-07-31 |
Euro Celtique Sa |
Pharmaceutical products
|
PT2279729T
(pt)
|
2003-07-17 |
2016-09-22 |
Banner Life Sciences Llc |
Preparações de libertação controlada
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
NZ545202A
(en)
|
2003-08-06 |
2010-03-26 |
Gruenenthal Chemie |
Abuse-proofed dosage form comprising opiods and a high molecular weight polyethylene oxide
|
ZA200601181B
(en)
|
2003-08-13 |
2007-04-25 |
Smith Howard J & Ass Pty Ltd |
Method of treating viral infections
|
US7470435B2
(en)
|
2003-11-17 |
2008-12-30 |
Andrx Pharmaceuticals, Llc |
Extended release venlafaxine formulation
|
FR2862536B1
(fr)
|
2003-11-21 |
2007-11-23 |
Flamel Tech Sa |
Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
|
TWI350762B
(en)
|
2004-02-12 |
2011-10-21 |
Euro Celtique Sa |
Particulates
|
DE102004032103A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
AU2005259478B2
(en)
|
2004-07-01 |
2010-07-15 |
Gruenenthal Gmbh |
Oral dosage form safeguarded against abuse containing (1R, 2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
|
PL1811979T3
(pl)
|
2004-09-27 |
2009-04-30 |
Sigmoid Pharma Ltd |
Mikrokapsułki zawierające metyloksantynę i kortykosteroid
|
CA2581002C
(en)
|
2004-10-15 |
2012-01-10 |
Supernus Pharmaceuticals, Inc. |
Less abusable pharmaceutical preparations
|
FR2878161B1
(fr)
|
2004-11-23 |
2008-10-31 |
Flamel Technologies Sa |
Forme medicamenteuse orale, solide et concue pour eviter le mesusage
|
FR2878158B1
(fr)
|
2004-11-24 |
2009-01-16 |
Flamel Technologies Sa |
Forme pharmaceutique orale, microparticulaire solide concue pour eviter le mesusage
|
FR2889810A1
(fr)
|
2005-05-24 |
2007-02-23 |
Flamel Technologies Sa |
Forme medicamenteuse orale, microparticulaire, anti-mesurage
|
FR2881652B1
(fr)
|
2005-02-08 |
2007-05-25 |
Flamel Technologies Sa |
Forme pharmaceutique orale microparticulaire anti-mesuage
|
US20070166378A1
(en)
*
|
2005-06-09 |
2007-07-19 |
Flamel Technologies, Inc. |
Oral ribavirin pharmaceutical compositions
|
WO2006133733A1
(en)
|
2005-06-13 |
2006-12-21 |
Flamel Technologies |
Oral dosage form comprising an antimisuse system
|
FR2892937B1
(fr)
|
2005-11-10 |
2013-04-05 |
Flamel Tech Sa |
Forme pharmaceutique orale microparticulaire anti-mesusage
|
US8652529B2
(en)
|
2005-11-10 |
2014-02-18 |
Flamel Technologies |
Anti-misuse microparticulate oral pharmaceutical form
|
FR2897267A1
(fr)
|
2006-02-16 |
2007-08-17 |
Flamel Technologies Sa |
Formes pharmaceutiques multimicroparticulaires pour administration per os
|
US9023400B2
(en)
|
2006-05-24 |
2015-05-05 |
Flamel Technologies |
Prolonged-release multimicroparticulate oral pharmaceutical form
|